New obesity drug shows promise in early trial
NCT ID NCT06350812
First seen Nov 19, 2025 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study tested a new medicine called PB-119 in 32 Chinese adults with obesity. The goal was to see if it is safe and helps with weight loss. Participants received either the drug or a placebo, and researchers measured side effects and weight changes over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Third XIANGYA Hospital of Central South University
Changsha, Hunan, 410013, China
Conditions
Explore the condition pages connected to this study.